Bulletin
Investor Alert

New York Markets Open in:

Greenwich LifeSciences

IPO: US:GLSI

Company Description

Phase 3 biotech developing immunotherapies for breast cancer.

Filing Information

File Date

6/1/2020

File Shares

2,946,264.00

Low Price Range

$5.75

High Price Range

$6.75

Proposed Offering Amount

$18,414,150

Exchange

Nasdaq

Underwriter Information

Bookrunner

Aegis Capital Corp.

Bookrunner

N/A

Bookrunner

N/A

At a Glance

Company

Greenwich LifeSciences

Address

City/State

Stafford, TX

Phone

N/A

Web

www.greenwichlifesciences.com

Industry

Health-Biotech

Employees

3

Founded

2006

Financial Information

Ltm Date

N/A

Ltm Sales

N/A

Employees

N/A

Use of Proceeds

Clinical trials

IPO Discussion

MarketWatch News on GLSI

Link to MarketWatch's Slice.